CB-03-01CB-03-01, a molecule patented by Cosmo, is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use.
The objective is to create a product for topical application to treat acne, male pattern baldness, and seborrhoea that does not have the side effects of products currently being taken in tablet form.
An IND was filed in the US for CB-03-01 for acne. Clinical trials are planned to start in the USA in Q2 2012.
Cosmo's patents expire in the year 2022 and 2028.
2012년에 출시한단는 말인가요???
2022년에 특허 만료된다는 말은 벌써..나왔다는 말인가??
해석좀..해주세요~~ㅜㅜ
☞ 본 게시판에서 모발이식 수술 후기는 신고 바랍니다. (삭제 및 탈퇴)
댓글 4